Personalis, Inc. Professional Fees
Personalis, Inc. (PSNL) reported Professional Fees of $4.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-04
- Personalis, Inc. professional fees for the quarter ending 2026-06-30 was $4.75M, a 82.87% increase year-over-year.
- Personalis, Inc. professional fees for the quarter ending 2026-03-31 was $3.82M, a 37.67% increase year-over-year.
- Personalis, Inc. professional fees for the quarter ending 2025-12-31 was $2.91M, a 65.26% increase year-over-year.
- Personalis, Inc. professional fees for the quarter ending 2025-09-30 was $2.97M, a 54.31% increase year-over-year.
- Personalis, Inc. professional fees for fiscal 2025 was $11.25M, a 23.89% increase from fiscal 2024.
- Personalis, Inc. professional fees for fiscal 2024 was $9.08M, a 27.06% decline from fiscal 2023.
- Personalis, Inc. professional fees for fiscal 2023 was $12.45M.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.75M 10-Q · filed 2026-08-04 | $8.57M 10-Q · filed 2026-08-04 | $11.48M derived: sum of 3 quarters · filed 2026-08-04 | $14.45M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.82M 10-Q · filed 2026-05-07 | $6.73M derived: sum of 2 quarters · filed 2026-05-07 | $9.70M derived: sum of 3 quarters · filed 2026-05-07 | $12.29M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.88M derived: sum of 2 quarters · filed 2026-02-26 | $8.47M derived: sum of 3 quarters · filed 2026-08-04 | $11.25M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.97M 10-Q · filed 2025-11-04 | $5.57M derived: sum of 2 quarters · filed 2026-08-04 | $8.34M 10-Q · filed 2025-11-04 | $10.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.60M 10-Q · filed 2026-08-04 | $5.37M 10-Q · filed 2026-08-04 | $7.13M derived: sum of 3 quarters · filed 2026-08-04 | $9.05M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.77M 10-Q · filed 2026-05-07 | $4.53M derived: sum of 2 quarters · filed 2026-05-07 | $6.46M derived: sum of 3 quarters · filed 2026-05-07 | $8.96M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.68M derived: sum of 2 quarters · filed 2026-02-26 | $6.19M derived: sum of 3 quarters · filed 2026-02-26 | $9.08M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.92M 10-Q · filed 2025-11-04 | $4.43M derived: sum of 2 quarters · filed 2025-11-04 | $7.32M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $2.51M 10-Q · filed 2025-08-05 | $5.40M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $2.89M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $12.45M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |